- Home
- GRAF vs AQST Comparison
GRAF vs AQST Comparison
Compare GRAF & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRAF
- AQST
- Stock Information
- Founded
- GRAF 2021
- AQST 2004
- Country
- GRAF United States
- AQST United States
- Employees
- GRAF N/A
- AQST N/A
- Industry
- GRAF
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- GRAF
- AQST Health Care
- Exchange
- GRAF NYSE
- AQST Nasdaq
- Market Cap
- GRAF 292.7M
- AQST 274.4M
- IPO Year
- GRAF 2024
- AQST 2018
- Fundamental
- Price
- GRAF $10.15
- AQST $2.84
- Analyst Decision
- GRAF
- AQST Strong Buy
- Analyst Count
- GRAF 0
- AQST 7
- Target Price
- GRAF N/A
- AQST $10.57
- AVG Volume (30 Days)
- GRAF 4.2K
- AQST 1.5M
- Earning Date
- GRAF 01-01-0001
- AQST 03-05-2025
- Dividend Yield
- GRAF N/A
- AQST N/A
- EPS Growth
- GRAF N/A
- AQST N/A
- EPS
- GRAF 0.30
- AQST N/A
- Revenue
- GRAF N/A
- AQST $57,561,000.00
- Revenue This Year
- GRAF N/A
- AQST N/A
- Revenue Next Year
- GRAF N/A
- AQST $35.72
- P/E Ratio
- GRAF $33.30
- AQST N/A
- Revenue Growth
- GRAF N/A
- AQST 13.80
- 52 Week Low
- GRAF $9.03
- AQST $2.24
- 52 Week High
- GRAF $11.02
- AQST $6.23
- Technical
- Relative Strength Index (RSI)
- GRAF N/A
- AQST 48.60
- Support Level
- GRAF N/A
- AQST $2.45
- Resistance Level
- GRAF N/A
- AQST $3.06
- Average True Range (ATR)
- GRAF 0.00
- AQST 0.22
- MACD
- GRAF 0.00
- AQST 0.02
- Stochastic Oscillator
- GRAF 0.00
- AQST 63.93
About GRAF GRAF GLOBAL CORP
Graf Global Corp is a blank check company.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.